Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,281–2,300 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Dryness Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC:17312-178-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-002-11.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Allergy Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-097-19.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-032-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-027-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Terminated Historical recordClass I

WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5

by Hua Da Trading, Inc. dba Wefun Inc.

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Recall initiated
August 25, 2023
Reported by FDA
September 20, 2023
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

by VistaPharm LLC

Reason
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Recall initiated
August 30, 2023
Reported by FDA
September 20, 2023
Distribution
Distributed nationwide to 68 consignees in the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.

by BE PHARMACEUTICALS AG

Reason
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Recall initiated
September 5, 2023
Reported by FDA
September 20, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC 10135-0748-01

by Marlex Pharmaceuticals, Inc.

Reason
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Recall initiated
August 25, 2023
Reported by FDA
September 13, 2023
Distribution
Nationwide in the US.

View recall →

Drug Recall Terminated Historical recordClass I

Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01

by Marlex Pharmaceuticals, Inc.

Reason
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Recall initiated
August 25, 2023
Reported by FDA
September 13, 2023
Distribution
Nationwide in the US.

View recall →

Drug Recall Terminated Historical recordClass II

Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. (60g) NDC 50268-195-60, Manufactured for: AvKARE, Pulaski, TN 38478

by AVKARE LLC

Reason
Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Recall initiated
August 11, 2023
Reported by FDA
September 13, 2023
Distribution
Affected product was distributed to nineteen (19) consignees within the united states.

View recall →

Drug Recall Terminated Historical recordClass II

Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus Mild Cleaning System Spearmint NET WT. 1.8 OZ. (51g), Rx only, NDC 42291-741-51, Manufactured for: AvKARE Pulaski, TN 38478

by AVKARE LLC

Reason
Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Recall initiated
August 11, 2023
Reported by FDA
September 13, 2023
Distribution
Affected product was distributed to nineteen (19) consignees within the united states.

View recall →

Drug Recall Terminated Historical recordClass III

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

by Ascend Laboratories, LLC

Reason
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Recall initiated
July 18, 2023
Reported by FDA
September 13, 2023
Distribution
The recall product was distributed nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

by Caplin Steriles Limited

Reason
Failed Impurities/Degradation Specifications
Recall initiated
August 14, 2023
Reported by FDA
September 13, 2023
Distribution
Nationwide in Tennessee

View recall →

Drug Recall Completed Historical recordClass III

Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03

by Esperion

Reason
Failed dissolution specifications: below specification results at stability 12-month
Recall initiated
August 16, 2023
Reported by FDA
September 13, 2023
Distribution
Nationwide USA

View recall →

Drug Recall Ongoing Historical recordClass I

Vegetal Vigra, 200mg capsules, 8-count bottle, Manufacturer: Hand-shaking (Int'l) Corp. USA ADD: Hand-shaking Mansion, the 5th Ave., Stanford, USA. UPC 8 931028 556885

by APG SEVEN, INC

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Recall initiated
August 3, 2023
Reported by FDA
September 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Completed Historical recordClass III

Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65

by Lundbeck LLC

Reason
Cross contamination with other products
Recall initiated
August 17, 2023
Reported by FDA
September 6, 2023
Distribution
Nationwide within the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pull ring, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA Product code L5B5193 NDC 0941-0411-07

by Baxter Healthcare Corporation

Reason
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Recall initiated
August 11, 2023
Reported by FDA
September 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

by Baxter Healthcare Corporation

Reason
Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.
Recall initiated
August 11, 2023
Reported by FDA
September 6, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

by Contract Pharmaceuticals Limited Canada

Reason
Defective Container: slow leakage under the cap
Recall initiated
August 23, 2023
Reported by FDA
September 6, 2023
Distribution
Nationwide in the USA.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.